trending Market Intelligence /marketintelligence/en/news-insights/trending/iNRV5mLUOiNGYCLvqt-2pw2 content esgSubNav
In This List

Flexion Therapeutics CFO retires

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Flexion Therapeutics CFO retires

Frederick Driscoll retired as the CFO of Flexion Therapeutics Inc., effective March 31.

Effective upon Driscoll's retirement, Flexion appointed CEO and President Michael Clayman as principal financial officer and principal accounting officer.

Driscoll is continuing to provide services as a part-time, nonexecutive employee while the company completes its on-going search for a new CFO.